EMD
EMYRIA LIMITED ORDINARYEmyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression. The company also develops ultra-pure CBD capsules (EMD-RX7, and EMD-RX9) and proprietary MDMA analogues, as well as provides psychological trauma care facility under the Pax Centre name. It has a collaboration partnership with the University of Western Australia to support the expand Emyria's MDMA analogue drug development program. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was incorporated in 2018 and is headquartered in Leederville, Australia.
EMD
EMD
EMYRIA LIMITED ORDINARY
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services, Clinical Services, and corporate segments.
Fundamentals
Historical Data53 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.00% | — |
| 10 July | 0.00% | — |
| 9 July | 0.00% | — |
| 8 July | 0.00% | — |
| 7 July | 0.00% | — |
| 6 July | 0.00% | — |
| 3 July | 0.00% | — |
| 2 July | 0.00% | — |
| 1 July | 0.00% | — |
Emyria Limited (EMD) Short Interest Summary
Emyria Limited (EMD) currently has 0.00% of its shares sold short (6 thousand shares, worth approximately $0K), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes EMD the #672 most shorted stock on the ASX most shorted list. Short interest in EMD is up 0.00% over the past week and up 0.00% over the past month. EMD is part of the Health Care sector on the ASX.
Recent EMD Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.00% | 0.0M | $0.04 |
| 10 July 2026 | 0.00% | 0.0M | $0.04 |
| 9 July 2026 | 0.00% | 0.0M | $0.04 |
| 8 July 2026 | 0.00% | 0.0M | $0.04 |
| 7 July 2026 | 0.00% | 0.0M | $0.04 |
| 6 July 2026 | 0.00% | 0.0M | $0.04 |
| 3 July 2026 | 0.00% | 0.0M | $0.04 |
| 2 July 2026 | 0.00% | 0.0M | $0.04 |
| 1 July 2026 | 0.00% | 0.0M | $0.04 |
| 30 June 2026 | 0.00% | 0.0M | $0.04 |
EMD Short Selling — Frequently Asked Questions
What is Emyria Limited (EMD)'s current short interest?
Emyria Limited (EMD) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of EMD's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is EMD heavily shorted on the ASX?
EMD has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for EMD investors?
Short interest in EMD shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, EMD's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this EMD short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for EMD.